ATE494549T1 - Screening-verfahren für heilmittel gegen herzkrankheit und medizinische zusammensetzung zur behandlung von herzkrankheit - Google Patents

Screening-verfahren für heilmittel gegen herzkrankheit und medizinische zusammensetzung zur behandlung von herzkrankheit

Info

Publication number
ATE494549T1
ATE494549T1 AT04727715T AT04727715T ATE494549T1 AT E494549 T1 ATE494549 T1 AT E494549T1 AT 04727715 T AT04727715 T AT 04727715T AT 04727715 T AT04727715 T AT 04727715T AT E494549 T1 ATE494549 T1 AT E494549T1
Authority
AT
Austria
Prior art keywords
heart disease
cardiac
disease
antibody
troponin
Prior art date
Application number
AT04727715T
Other languages
English (en)
Inventor
Tasuku Honjo
Taku Okazaki
Original Assignee
Ono Pharmaceutical Co
Tasuku Honjo
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Ono Pharmaceutical Co, Tasuku Honjo filed Critical Ono Pharmaceutical Co
Priority claimed from PCT/JP2004/005382 external-priority patent/WO2004091476A1/ja
Application granted granted Critical
Publication of ATE494549T1 publication Critical patent/ATE494549T1/de

Links

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/564—Immunoassay; Biospecific binding assay; Materials therefor for pre-existing immune complex or autoimmune disease, i.e. systemic lupus erythematosus, rheumatoid arthritis, multiple sclerosis, rheumatoid factors or complement components C1-C9
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/04—Inotropic agents, i.e. stimulants of cardiac contraction; Drugs for heart failure
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/5005—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells
    • G01N33/5008—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics
    • G01N33/5044—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics involving specific cell types
    • G01N33/5061—Muscle cells
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2800/00—Detection or diagnosis of diseases
    • G01N2800/32—Cardiovascular disorders
    • G01N2800/325—Heart failure or cardiac arrest, e.g. cardiomyopathy, congestive heart failure

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Immunology (AREA)
  • Chemical & Material Sciences (AREA)
  • Hematology (AREA)
  • Biomedical Technology (AREA)
  • Cell Biology (AREA)
  • Molecular Biology (AREA)
  • Medicinal Chemistry (AREA)
  • Urology & Nephrology (AREA)
  • General Health & Medical Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Biotechnology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Food Science & Technology (AREA)
  • Physics & Mathematics (AREA)
  • Analytical Chemistry (AREA)
  • Biochemistry (AREA)
  • Microbiology (AREA)
  • General Physics & Mathematics (AREA)
  • Pathology (AREA)
  • Cardiology (AREA)
  • Organic Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Toxicology (AREA)
  • Epidemiology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Zoology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Rheumatology (AREA)
  • Rehabilitation Therapy (AREA)
  • Hospice & Palliative Care (AREA)
AT04727715T 2003-04-16 2004-04-15 Screening-verfahren für heilmittel gegen herzkrankheit und medizinische zusammensetzung zur behandlung von herzkrankheit ATE494549T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP2003111703 2003-04-16
PCT/JP2004/005382 WO2004091476A1 (ja) 2003-04-16 2004-04-15 心臓疾患治療物質のスクリーニング方法および心臓疾患治療医薬組成物

Publications (1)

Publication Number Publication Date
ATE494549T1 true ATE494549T1 (de) 2011-01-15

Family

ID=33296005

Family Applications (1)

Application Number Title Priority Date Filing Date
AT04727715T ATE494549T1 (de) 2003-04-16 2004-04-15 Screening-verfahren für heilmittel gegen herzkrankheit und medizinische zusammensetzung zur behandlung von herzkrankheit

Country Status (5)

Country Link
US (1) US7407767B2 (de)
EP (1) EP1619498B1 (de)
JP (1) JP4545685B2 (de)
AT (1) ATE494549T1 (de)
DE (1) DE602004030898D1 (de)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20070172888A1 (en) * 2006-01-25 2007-07-26 Klaus Hallermayer Measuring troponin antibodies to assess cardiovascular risk
US20080305512A1 (en) * 2006-10-26 2008-12-11 Mattingly Phillip G Assay for cardiac troponin autoantibodies
MX2009004460A (es) 2006-10-26 2009-07-09 Abbott Lab Inmunoensayo de analitos en muestras que contienen anticuerpos anti-analito endogenos.
US7776605B2 (en) * 2006-10-26 2010-08-17 Abbott Laboratories Assay for cardiac troponin autoantibodies
US7601689B2 (en) * 2007-04-12 2009-10-13 Naidu Lp Angiogenin complexes (ANGex) and uses thereof
US8420330B2 (en) 2011-07-15 2013-04-16 Myra A. Lipes Diagnosis and treatment of cardiac troponin 1 (cTn1) autoantibody-mediated heart disease
WO2010129302A1 (en) * 2009-04-28 2010-11-11 Innovative Laboratory Technologies, Inc. Lateral-flow immuno-chromatographic assay devices
AU2011265239A1 (en) * 2010-06-10 2013-01-24 Lizbeth Cornivelli Diagnosis of myocardial autoimmunity in heart disease
US20130121998A1 (en) * 2010-06-16 2013-05-16 Myra A. Lipes Diagnosis of Myocardial Autoimmunity in Heart Disease

Family Cites Families (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4637880A (en) * 1981-11-30 1987-01-20 Cordis Laboratories, Inc. Apparatus and method for therapeutic immunodepletion
AU689777B2 (en) * 1993-05-17 1998-04-09 Fortron Bioscience, Inc. Assay for cardiac troponin I
US7119248B1 (en) * 1994-04-12 2006-10-10 Miltenyi Biotec Gmbh Antibodies against epitopes with homology to self antigens, methods of preparation and applications thereof
US5534615A (en) * 1994-04-25 1996-07-09 Genentech, Inc. Cardiac hypertrophy factor and uses therefor
WO1996010076A1 (en) * 1994-09-28 1996-04-04 Spectral Diagnostics Inc. A monoclonal antibody to human cardiac troponin i
FR2729759A1 (fr) * 1995-01-19 1996-07-26 Pasteur Sanofi Diagnostics Procede de dosage ultrasensible de la troponine i cardiaque
US5795725A (en) * 1995-04-18 1998-08-18 Biosite Diagnostics Incorporated Methods for the assay of troponin I and T and selection of antibodies for use in immunoassays
JP2001525535A (ja) * 1997-09-04 2001-12-11 ボード オブ トラスティーズ オブ レランド スタンフォード ジュニア ユニバーシティ 細胞骨格機能のモジュレーターを検出するためのアッセイ
AU6117099A (en) 1998-10-21 2000-05-08 Spectral Diagnostics Inc. Cardiac troponin i polypeptide fragments and uses in diagnostics
US6495376B1 (en) * 1999-02-18 2002-12-17 Beth Israel Deaconess Medical Center Methods and compositions for regulating protein-protein interactions
JP2002539161A (ja) 1999-03-15 2002-11-19 ボストン ライフ サイエンシズ，インコーポレーテッド． トロポニンサブユニット、それらの断片および相同体を含む医薬組成物ならびに血管形成を抑制するためのそれらの使用方法
US7064180B2 (en) * 2000-07-31 2006-06-20 The General Hospital Corporation High affinity integrin polypeptides and uses thereof
JP3871326B2 (ja) 2000-11-15 2007-01-24 小野薬品工業株式会社 Ｐｄ−１欠損マウスおよびその用途
NZ529359A (en) * 2001-05-25 2007-04-27 Human Genome Sciences Inc Antibodies that immunospecifically bind to a TR4 polypeptide or polypeptide fragment or variant of TR4 and their use in a medicament for treating cancer
CA2453438C (en) 2001-07-12 2016-04-05 Geron Corporation Cells of the cardiomyocyte lineage produced from human pluripotent stem cells

Also Published As

Publication number Publication date
EP1619498A2 (de) 2006-01-25
WO2004091476A2 (ja) 2004-10-28
EP1619498B1 (de) 2011-01-05
WO2004091476A3 (ja) 2005-03-03
DE602004030898D1 (de) 2011-02-17
US20060246525A1 (en) 2006-11-02
EP1619498A4 (de) 2006-06-14
US7407767B2 (en) 2008-08-05
JPWO2004091476A1 (ja) 2006-07-06
JP4545685B2 (ja) 2010-09-15

Similar Documents

Publication Publication Date Title
Main et al. Murine axial compression tibial loading model to study bone mechanobiology: implementing the model and reporting results
Nitzan-Luques et al. Genotype-selective phenotypic switch in primary afferent neurons contributes to neuropathic pain
Ho et al. Repair with collagen tubules linked with brain-derived neurotrophic factor and ciliary neurotrophic factor in a rat sciatic nerve injury model
Childers et al. Eccentric contraction injury in dystrophic canine muscle
Wang et al. Accelerated chondrogenesis of the rabbit cranial base growth plate by oscillatory mechanical stimuli
EP2314617A3 (de) ActRII-Rezeptor-Polypeptide
ATE494549T1 (de) Screening-verfahren für heilmittel gegen herzkrankheit und medizinische zusammensetzung zur behandlung von herzkrankheit
EP3269815A3 (de) Behandlungsverfahren und screeningverfahren
Casal et al. Reconstruction of a 10-mm-long median nerve gap in an ischemic environment using autologous conduits with different patterns of blood supply: A comparative study in the rat
Zhang et al. Knee loading accelerates bone healing in mice
Schuelke et al. Intramembranous bone formation after callus distraction is augmented by increasing axial compressive strain
Deng et al. Optogenetic neuronal stimulation promotes functional recovery after spinal cord injury
Li et al. Dose‐dependent effect of radiation on titanium implants: a quantitative study in rabbits
Hu et al. Laser doppler perfusion imaging of skin territory to reflect autonomic functional recovery following sciatic nerve autografting repair in rats
DE60122673D1 (de) Methoden zur diagnose und behandlung von herzkrankheiten
Medeiros et al. Glutamatergic neurotransmission in the inferior colliculus influences intrastriatal haloperidol-induced catalepsy
Shen et al. Modeling complex orthopedic trauma in rodents: bone, muscle and nerve injury and healing
Glass et al. Progressive protrusive tongue exercise does not alter aging effects in retrusive tongue muscles
Legrand et al. Efficacy of chronic ultrasound neurostimulation on behaviors and distributed brain metabolism in depressive-like mice
KR20150117890A (ko) 척수 손상 동물모델 제조방법 및 이를 통해 제조된 척수 손상 동물모델
Concha-Miranda et al. Large-scale mapping of vocalization-related activity in the functionally diverse nuclei in rat posterior brainstem
Hansen et al. In-vivo analysis of nerve regeneration after sciatic nerve injury in a rat model
Rupert et al. Mouse hind limb skeletal muscle functional adaptation in a simulated fine branch arboreal habitat
von Rechenberg Animal models in bone repair
Wright Navicular suspensory desmotomy in the treatment of navicular disease: technique and preliminary results

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties